Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
M3 ( (JP:2413) ) just unveiled an announcement.
M3, Inc. has announced the status of its share repurchase program, which was approved by its Board of Directors. The company repurchased 164,300 common shares for approximately 338.6 million yen between June 1 and June 30, 2025, as part of a broader plan to repurchase up to 20 million shares by April 2026. This move is part of M3’s strategic financial management, potentially impacting shareholder value and market perception.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen3300.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, focusing on providing medical-related services and solutions. The company is known for its digital health platforms and services that cater to healthcare professionals and institutions, enhancing medical communication and efficiency.
YTD Price Performance: 37.41%
Average Trading Volume: 3,739,262
Technical Sentiment Signal: Hold
Current Market Cap: Yen1287.1B
Find detailed analytics on 2413 stock on TipRanks’ Stock Analysis page.